ARTICLE | Company News
Galena Biopharma, Mills Pharmaceuticals deal
January 20, 2014 8:00 AM UTC
Galena acquired Mills Pharmaceuticals for about $1.6 million cash up front. Galena gains exclusive, worldwide rights to anagrelide CR ( GALE-401), a controlled-release formulation of generic anti-pla...